Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Global Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-based pharmaceutical manufacturer with branded products, manufacturing operations and an expanding international footprint.

Global Pharmaceuticals products in Pakistan

Global Pharmaceuticals (Pvt.) Ltd has 220 medicine presentations registered in Pakistan under 94 brands, covering 79 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and CNS & mental health. Its brands with the most registered strengths and packs are Clavopin (Amoxicillin + clavulanic acid), Eppra (Levetiracetam), Norbac (Ceftriaxone) and Nafcin (Ciprofloxacin). 220 products have an official DRAP price on MedInfoBase. See all 94 brands A to Z

Database-driven profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public source rechecked
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence8 sourcesCorporate source details checked 23 Oct 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public source rechecked
Company type
Private pharmaceutical manufacturer
Address
Plot 22-23, Industrial Triangle, Kahuta Road, Islamabad, Pakistan
Phone
+92 336 5559068
Official contact
Contact page ↗
Corporate source details checked
23 Oct 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000417 Global Pharmaceuticals. · Islamabad
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000417 211 linked products · source seen 13 Nov 2026 View source ↗
DML 000724 10 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx238public portfolio records represented
REG181unique registrations represented
IDX24indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER99registry-verified exact registrations
PKR220current validated price records
G79generic molecules in indexed catalogue
DF10dosage-form groups
TA15therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage92%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage85%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixGlobal Pharmaceuticals (Pvt.) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/global-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026Anti-infectives115 · 52%Gastrointestinal & hepatology19 · 9%CNS & mental health17 · 8%Vitamins, minerals & nutrition15 · 7%Oncology & immunology9 · 4%Cardiovascular8 · 4%Hematology & thrombosis8 · 4%Other therapeutic areas29 · 13%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioGlobal Pharmaceuticals (Pvt.) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/global-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026220presentationsInjection75 · 34%Tablet69 · 31%Capsule28 · 13%Suspension20 · 9%Syrup13 · 6%Cream7 · 3%Other forms8 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionGlobal Pharmaceuticals (Pvt.) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/global-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026188comparable productsBelow peer median61 · 32%Near peer median52 · 28%Above peer median75 · 40%Company median price position+1.4%Lowest-price equivalents10Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsGlobal Pharmaceuticals (Pvt.) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/global-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026M/s. Genix Pharma (Pvt) Ltd.45 shared57% overlapPharmasol (Pvt) Ltd.42 shared53% overlapNeutro Pharma (Pvt.) Ltd.,41 shared52% overlapZafa Pharmaceutical Laboratories (P…40 shared51% overlapBio-Labs(Pvt) Ltd40 shared51% overlapBosch Pharmaceuticals (Pvt) Ltd.39 shared49% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Injection75 products
Tablet69 products
Capsule28 products
Suspension20 products
Syrup13 products
Cream7 products
Infusion3 products
Ointment2 products
Solution2 products
Gel1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Global Pharmaceuticals (Pvt.) Ltd. is priced against the market

188 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers163Distinct registrations among indexed, published, presentation-validated products only
Verified price observations220
Products with a verified price220
Products with multiple price observations0
Source records with multiple versions219
Latest portfolio source check12 Oct 2026
Latest effective price date27 Jul 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

181 unique registration(s) · 24 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
E-REL Ceftriaxone 250 mg Injection 1's 099554 PKR 170.51 PKR 170.51/vial/unit 🔒 Pharma Pro
E-REL Ceftriaxone 500 mg Injection 1's 099555 PKR 287.00 PKR 287.00/vial/unit 🔒 Pharma Pro
E-REL Ceftriaxone 2 g Injection 1's 099557 PKR 759.70 PKR 759.70/vial/unit 🔒 Pharma Pro
Maxophine Cefixime 100 mg/5 mL Dry suspension 30ml 030553 PKR 314.24 PKR 10.47/mL 🔒 Pharma Pro
Maxophine Cefixime 400 mg Capsule 5's 030562 PKR 592.02 PKR 118.40/capsule 🔒 Pharma Pro
Maxophine Cefixime 400 mg Capsule 1x6's 030562 PKR 710.43 PKR 118.41/capsule 🔒 Pharma Pro
Maxophine Cefixime 200 mg Capsule 10's 056623 PKR 646.44 PKR 64.64/capsule 🔒 Pharma Pro
Maxophine Plus Cefixime 200 mg/5 mL Dry suspension 30ml 054728 PKR 384.55 PKR 12.82/mL 🔒 Pharma Pro
Norbac Ceftriaxone 250 mg Injection 1 Vial 025928 PKR 227.18 PKR 227.18/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 0.25 g Injection 7 Vials 025928 PKR 1,565.48 PKR 223.64/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 500 mg Injection 1 Vial 025929 PKR 388.27 PKR 388.27/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 0.5 g Injection 7 Vials 025929 PKR 2,691.04 PKR 384.43/vial/unit No comparator
Norbac Ceftriaxone 1 g Injection 1 Vial 025930 PKR 764.15 PKR 764.15/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 1.0 g Injection 7 Vials 025930 PKR 5,080.55 PKR 725.79/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 250 mg Injection 1's 033391 PKR 208.60 PKR 208.60/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 500 mg Injection 1's 033792 PKR 351.09 PKR 351.09/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 1000 mg Injection 1's 033793 PKR 662.95 PKR 662.95/vial/unit 🔒 Pharma Pro
Norbac Ceftriaxone 2 g IV injection 1's 094175 PKR 873.67 PKR 873.67/vial/unit 🔒 Pharma Pro
Sporonil Cefotaxime 250 mg IM/IV injection 7 Vials 025925 PKR 745.13 PKR 106.45/vial/unit 🔒 Pharma Pro
Sporonil Cefotaxime 250 mg Injection 1 Vial 025925 PKR 105.47 PKR 105.47/vial/unit 🔒 Pharma Pro
Sporonil Cefotaxime 500 mg Injection 7 Vials 025926 PKR 1,123.04 PKR 160.43/vial/unit 🔒 Pharma Pro
Sporonil Cefotaxime 500 mg Injection 1 Vial 025926 PKR 158.95 PKR 158.95/vial/unit 🔒 Pharma Pro
Sporonil Cefotaxime 1 g Injection 7 vials 025927 PKR 2,019.84 PKR 288.55/vial/unit 🔒 Pharma Pro
Sporonil Cefotaxime 1 g Injection 1 Vial 025927 PKR 285.88 PKR 285.88/vial/unit 🔒 Pharma Pro
A to Z

All 94 Global Pharmaceuticals brands in Pakistan

  • Anarob Metronidazole · 500 mg infusion
  • Besone Ointment Betamethasone dipropionate · 0.64 % ointment
  • Calciferol Cholecalciferol · 1000 IU injection, 5 mg injection, 5 mg/mL injection
  • Clarabac Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
  • Clavopin Amoxicillin + clavulanic acid · 1 g + 200 mg injection, 1000 mg + 200 mg injection, 125 mg + 31 mg syrup
  • Co-Telmas Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
  • Cordin Chlorhexidine gluconate · 4% gel
  • Cure-B Entecavir · 0.5 mg tablet, 1 mg tablet
  • Cure-C Sofosbuvir · 400 mg tablet
  • Cure-C Forte Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
  • DEXASONE Dexamethasone · 4 mg injection
  • Digitek Digoxin · 0.25 mg tablet
  • Doxicap Doxycycline · 100 mg capsule
  • E-REL Ceftriaxone · 2 g injection, 250 mg injection, 500 mg injection
  • Emvoid Aprepitant · 125 mg capsule, 40 mg capsule, 80 mg capsule
  • Eppra Levetiracetam · 100 mg/mL solution, 250 mg tablet, 500 mg tablet
  • Femeg Clomifene citrate · 50 mg tablet
  • Fericard Warfarin · 5 mg tablet
  • Feromalt Iron polymaltose complex, Iron · 50 mg elemental iron/5 mL syrup, 50 mg/5 mL syrup
  • Fevonor Paracetamol · 120 mg/5 mL suspension
  • Fevonor plus Paracetamol · 250 mg/5 mL suspension
  • Fungicure Fluconazole · 150 mg capsule
  • Fungiderm-I Clotrimazole · 500 mg tablet
  • G-Lac Lactulose · 3.35 g/5 mL syrup
  • G-Plex Iron protein succinylate · 40 mg/15 mL syrup
  • G-Sac Amlodipine · 5 mg tablet
  • Gcilin Ampicillin · 500 mg injection
  • Glinza Daclatasvir · 60 mg tablet
  • Global-C Ascorbic acid · 500 mg tablet
  • Globutol Ethambutol · 400 mg tablet
  • Glodium Loperamide HCl · 2 mg capsule
  • Gloxil Amoxicillin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg injection
  • Gloxil Forte Dry Amoxicillin · 250 mg/5 mL suspension
  • Glozil Azithromycin · 500 mg tablet
  • Hi-Cort Triamcinolone Acetonide · 40 mg injection
  • Imtac Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
  • Jazin Empagliflozin · 10 mg tablet, 25 mg tablet
  • Ketarol Ketamine · 500 mg injection
  • Letglo Letrozole · 2.5 mg tablet
  • Levaq Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • Lignocane Lidocaine · 1 % injection
  • Lignocane 2ml Lidocaine · 1 % injection
  • Linzy Linezolid · 100 mg/5 mL suspension, 600 mg tablet
  • Linzy IV Linezolid · 2 mg/mL infusion
  • Lisnozide Lisinopril · 20 mg tablet
  • Maxophine Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
  • Maxophine Plus Cefixime · 200 mg/5 mL suspension
  • Mazine Silver sulfadiazine · 10 mg/g cream
  • Mediclop Metoclopramide · 10 mg tablet, 10 mg injection
  • MEGPHATE Magnesium sulfate · 500 mg injection
  • Merem Meropenem · 1 g injection, 500 mg injection
  • Mesnex Mesna · 400 mg/4 mL injection
  • Mikacin Amikacin · 100 mg injection, 500 mg injection
  • Miso Misoprostol · 100 mcg tablet, 200 mcg tablet
  • Mizam Midazolam · 5 mg/5 mL injection, 7.5 mg tablet
  • Mythrin Permethrin · 50 mg/g cream
  • Nafcin Ciprofloxacin · 125 mg/5 mL suspension, 2 mg injection, 250 mg tablet
  • Nimoconil Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
  • Nimoconil Dry Azithromycin · 200 mg/5 mL suspension
  • Norbac Ceftriaxone · 0.25 g injection, 0.5 g injection, 1 g injection
  • Opepzole Omeprazole · 40 mg injection
  • Peridal Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Profol Propofol · 10 mg/mL injection
  • Propen Ibuprofen · 400 mg tablet
  • Prosta Ibuprofen · 100 mg/5 mL suspension, 600 mg tablet
  • Protole Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
  • Relem Meropenem · 1 g injection, 500 mg injection
  • Reli-Chole Cholecalciferol · 5 mg/mL injection
  • Reli-prazole Omeprazole · 40 mg injection
  • Renorm Atorvastatin · 10 mg tablet
  • Rim-J Rifampicin · 100 mg/5 mL suspension
  • Rimactal Rifampicin · 300 mg capsule
  • Rimactal INH Rifampicin + Isoniazid · 150 mg + 150 mg tablet, 300 mg + 150 mg tablet
  • Rimactal INH 300 Rifampicin + Isoniazid · 300 mg + 150 mg tablet
  • Rimstar s Rifampicin + Isoniazid + Pyrazinamide + Ethambutol · 150 mg + 75 mg + 400 mg + 275 mg tablet
  • Rimthree - FDC Rifampicin + Isoniazid · 150 mg + 75 mg tablet
  • Sporonil Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Succicort Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
  • Tazocillin Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
  • Tebrovate Betamethasone valerate · 1 mg/g ointment
  • Terbister Terbinafine · 1 % cream
  • Thionol Thiopental · 500 mg injection
  • Tinearin Miconazole · 2% w/w cream
  • Transolide Tranexamic acid · 1 g injection, 250 mg/5 mL injection, 500 mg/5 mL injection
  • Virglo Valganciclovir · 450 mg tablet
  • Viro-B Tenofovir disoproxil · 300 mg tablet
  • Water for Injection Water for Injection · Sterile solvent injection
  • Xefra Deferasirox · 125 mg tablet, 250 mg tablet, 400 mg tablet
  • Xymox Moxifloxacin · 400 mg tablet
  • Zeesup Zinc · 20 mg tablet
  • Zinorox Cefuroxime · 250 mg injection, 750 mg injection
  • Zolasta Zoledronic acid · 4 mg/5 mL infusion
  • Zordin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • Zoycin Piperacillin, Piperacillin + tazobactam · 2.25 g injection, 4 g + 0.5 g injection
Questions

Global Pharmaceuticals: common questions

How many products does Global Pharmaceuticals have in Pakistan?

Global Pharmaceuticals (Pvt.) Ltd has 220 registered medicine presentations in Pakistan, sold under 94 brands and covering 79 generic medicines.

What are the main brands of Global Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Clavopin (Amoxicillin + clavulanic acid), Eppra (Levetiracetam), Norbac (Ceftriaxone), Nafcin (Ciprofloxacin) and Calciferol (Cholecalciferol). This is not a sales ranking.

Which therapy areas does Global Pharmaceuticals cover?

The most products are in Anti-infectives (115), Gastrointestinal & hepatology (19), CNS & mental health (17), Vitamins, minerals & nutrition (15) and Oncology & immunology (9).

Where can I see Global Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Global Pharmaceuticals (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/global-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9